Immunitas Therapeutics employs a single cell genomics platform to dissect the biology of immune cells in human tumors, thereby advancing discoveries directly from the bench into meaningful clinical improvements. Our focus on human data allows us to start with and stay closer to the biology that is most relevant in patients and greatly accelerates the pace of our research.
Market
Cancer therapeutics
Location
Cambridge,
MA,
USA
Coinvestors
Alexandria Venture Investments, Evotec, Leaps by Bayer, M Ventures, Novartis Venture Fund